Creative Planning
PTLA

Creative Planning’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Creative Planning’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-187,029
Closed -$1.33M – 2182
2020
Q1 		$1.33M Buy
187,029
+590
+0.3% +$7.36K ﹤0.01% 547
2019
Q4 		$4.45M Buy
186,439
+248
+0.1% +$6.84K 0.01% 318
2019
Q3 		$4.99M Sell
186,191
-16,297
-8% -$457K 0.02% 285
2019
Q2 		$5.49M Sell
202,488
-125,272
-38% -$3.93M 0.02% 270
2019
Q1 		$11.4M Buy
327,760
+24,860
+8% +$717K 0.04% 147
2018
Q4 		$5.91M Buy
302,900
+85,943
+40% +$1.77M 0.02% 210
2018
Q3 		$5.78M Buy
216,957
+82,055
+61% +$2.68M 0.02% 244
2018
Q2 		$5.09M Buy
134,902
+81,202
+151% +$3.11M 0.02% 251
2018
Q1 		$1.75M Buy
53,700
+14,434
+37% +$633K 0.01% 503
2017
Q4 		$1.91M Sell
39,266
-1,160
-3% -$58.7K 0.01% 473
2017
Q3 		$2.18M Buy
40,426
+2,343
+6% +$138K 0.01% 433
2017
Q2 		$2.14M Sell
38,083
-5,790
-13% -$232K 0.01% 421
2017
Q1 		$1.72M Sell
43,873
-9,070
-17% -$289K 0.01% 475
2016
Q4 		$1.19M Buy
52,943
+30,393
+135% +$594K 0.01% 565
2016
Q3 		$512K Buy
22,550
+1,500
+7% +$35.2K ﹤0.01% 880
2016
Q2 		$497K Buy
21,050
+4,755
+29% +$117K ﹤0.01% 782
2016
Q1 		$332K Sell
16,295
-1,755
-10% -$55.7K ﹤0.01% 937
2015
Q4 		$929K Buy
18,050
+300
+2% +$14.5K 0.01% 526
2015
Q3 		$757K Sell
17,750
-1,055
-6% -$50.9K 0.01% 572
2015
Q2 		$857K Buy
18,805
+18,205
+3,034% +$732K 0.01% 514
2015
Q1 		$23K Buy
+600
New +$20.6K ﹤0.01% 2623

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Creative Planning's PTLA Position: Q2 2020 in Review

Creative Planning sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 187,029 shares — an estimated $1.33M sold.

Creative Planning first reported a position in PTLA in Q1 2015 and held it in 21 quarters. The position peaked at $11.4M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Creative Planning reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Creative Planning sold 187,029 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.33M.
  • Creative Planning first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 21 quarters.
  • Creative Planning's Portola Pharmaceuticals, Inc. position peaked at $11.4M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.